Open access
Sep 2026
Beyond tumor DNA: Establishing OncoMRD BREAST as a novel cell-free mRNA biomarker of breast tumor activity for minimal residual disease monitoring
By capturing tumor-, immune-, and microenvironment-associated transcriptional programs, OncoMRD BREAST offers a biologically relevant and potentially complementary approach to ctDNA-based MRD monitoring, supporting a new paradigm of functional residual disease assessment in breast cancer.
Chen Yeh
· Innovative Medicines & O... · 0 citations